Mark Demitrack Trevena Inc (TRVN) insider trading activity
Mark Demitrack is SVP, Chief Medical Officer of TREVENA INC. Currently has a direct ownership of 306,224 shares of TRVN, which is worth approximately $67,369. The most recent transaction as insider was on Dec 14, 2023, when has been sold 3,593 shares (Common Stock) at a price of $0.61 per share, resulting in proceeds of $2,191. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
306K
0%
3M change
282.65%
12M change
Total Value Held
$67,369
Mark Demitrack Transaction History
MD
Mark Demitrack
SVP, Chief Medical Officer
Chesterbrook, PA